phosphotyrosine has been researched along with Fragile X Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krasovska, V; Reynolds, KE; Scott, AL | 1 |
1 other study(ies) available for phosphotyrosine and Fragile X Syndrome
| Article | Year |
|---|---|
Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3.
Topics: Animals; Astrocytes; Cells, Cultured; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Interleukin-6; Male; Mice; Mice, Knockout; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Purinergic P2Y Receptor Agonists; Receptors, Interleukin-6; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Tenascin; Toll-Like Receptor 4; Uridine Triphosphate | 2021 |